Clinical Trial Update: Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the immunogenicity and safety of a fifth booster dose of the diphtheria-tetanus-pertussis-polio vaccine. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Diphtheria-Tetanus-Pertussis-Polio Vaccine (Diphtheria, Tetanus, Pertussis, and Poliomyelitis vaccine)

Snippet

Sponsor: Norwegian Institute of Public Health | Conditions: Diphtheria, Tetanus | Phase 4 | Status: COMPLETED